Ahead of regulators, UK prepares vaccine rollout
PM Johnson sees Easter as a return to normal
LONDON – With major COVID-19 vaccines showing high levels of protection, British officials are cautiously – and they stress cautiously – optimistic that life may start returning to normal by early April.
Even before regulators have approved a single vaccine, the U.K. and countries across Europe are moving quickly to organize the distribution and delivery systems needed to inoculate millions of citizens.
“If we can roll it out at a good lick ... then with a favorable wind, this is entirely hypothetical, but we should be able to inoculate, I believe on the evidence I’m seeing, the vast majority of the people who need the most protection by Easter,” Prime Minister Boris Johnson said Monday after vaccine makers in recent weeks have announced encouraging results. “That will make a very substantial change to where we are at the moment.”
The United Kingdom has recorded more than 55,000 deaths linked to COVID-19, the deadliest outbreak in Europe. The pandemic has prevented families from meeting, put 750,000 people out of work and devastated businesses that were forced to shut as authorities tried to control the spread. England’s second national lockdown will end Dec. 2, but many restrictions will remain in place.
The British government has agreed to purchase up to 355 million doses of vaccine from seven different producers, as it prepares to vaccinate as
many of the country’s 67 million people as possible. Governments around the world are making agreements with multiple developers to ensure they lock in delivery of the products that are ultimately approved by regulators.
The National Health Service is making plans to administer 88.5 million vaccine doses throughout England, according to a planning document dated Nov. 13. Scotland, Wales and Northern Ireland are developing their own plans.
The first to be vaccinated would be health care workers and nursing home residents, followed by older people, starting with those over 80, according to the document, first reported by the London-based Health Service Journal. People under 65 with underlying medical conditions would be next, then healthy people 50 to 65, and finally everyone else 18 and over.
While most of the injections would be delivered at about 1,000 community vaccination centers, about a third would go to 40 to 50 “large-scale mass vaccination centers,” including stadiums, conference centers and similar venues, the document indicates.
Professor Mark Jit, an expert in vaccine epidemiology at the London School of Hygiene & Tropical Medicine, said Britain has the advantage of having a well-developed medical infrastructure that can be used to deliver the vaccine.
“The challenge now is to deliver the biggest vaccine program in living memory in the U.K. and other countries around the world,” Jit said. “We’re not vaccinating just children or pregnant women like many other vaccination programs. ... We’re trying to vaccinate the entire U.K. population. And we’re trying to do it very quickly.”